Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation. Diabetes Care 2013;36:e201

Detalles Bibliográficos
Autores principales: Philla, Katherine Q., Bauer, Andrew J., Vogt, Karen S., Greeley, Siri Atma W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Errata
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392914/
http://dx.doi.org/10.2337/dc14-er02b
_version_ 1782366064663855104
author Philla, Katherine Q.
Bauer, Andrew J.
Vogt, Karen S.
Greeley, Siri Atma W.
author_facet Philla, Katherine Q.
Bauer, Andrew J.
Vogt, Karen S.
Greeley, Siri Atma W.
author_sort Philla, Katherine Q.
collection PubMed
description
format Online
Article
Text
id pubmed-4392914
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-43929142015-04-13 Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation. Diabetes Care 2013;36:e201 Philla, Katherine Q. Bauer, Andrew J. Vogt, Karen S. Greeley, Siri Atma W. Diabetes Care Errata American Diabetes Association 2014-02 2014-01-11 /pmc/articles/PMC4392914/ http://dx.doi.org/10.2337/dc14-er02b Text en © 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Errata
Philla, Katherine Q.
Bauer, Andrew J.
Vogt, Karen S.
Greeley, Siri Atma W.
Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation. Diabetes Care 2013;36:e201
title Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation. Diabetes Care 2013;36:e201
title_full Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation. Diabetes Care 2013;36:e201
title_fullStr Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation. Diabetes Care 2013;36:e201
title_full_unstemmed Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation. Diabetes Care 2013;36:e201
title_short Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation. Diabetes Care 2013;36:e201
title_sort successful transition from insulin to sulfonylurea therapy in a patient with monogenic neonatal diabetes owing to a kcnj11 p333l mutation. diabetes care 2013;36:e201
topic Errata
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392914/
http://dx.doi.org/10.2337/dc14-er02b
work_keys_str_mv AT phillakatherineq successfultransitionfrominsulintosulfonylureatherapyinapatientwithmonogenicneonataldiabetesowingtoakcnj11p333lmutationdiabetescare201336e201
AT bauerandrewj successfultransitionfrominsulintosulfonylureatherapyinapatientwithmonogenicneonataldiabetesowingtoakcnj11p333lmutationdiabetescare201336e201
AT vogtkarens successfultransitionfrominsulintosulfonylureatherapyinapatientwithmonogenicneonataldiabetesowingtoakcnj11p333lmutationdiabetescare201336e201
AT greeleysiriatmaw successfultransitionfrominsulintosulfonylureatherapyinapatientwithmonogenicneonataldiabetesowingtoakcnj11p333lmutationdiabetescare201336e201

Ejemplares similares